Beyond its myocardial expression, elevated circulating levels of SERPINA3 have been linked to an increased cancer risk in heart failure patients, highlighting the necessity for more in-depth exploration of its clinical implications and molecular functions (55). The gene discussed is SERPINA3; the disease is heart failure.